Mesa Laboratories, Inc (NASDAQ:MLAB) Shows Undervalued Metrics, Poised For Near-Term Reassessment
![]() |
Robust free cash flow and a quarterly dividend contrast with compressed operating margins and heavy leverage, creating a mixed but actionable near-term setup for price reassessment. |








